Impacts20d
The Role of Vertex Pharmaceuticals in Boston’s Biotech Boom
As the sun rises over the vibrant skyline of Boston, it illuminates not just a beautiful city, but also one of the most ...
Business Wire24d
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral ...
The Boston Globe27d
Moderna, Vertex receive over $5 million each in Massachusetts tax breaks for job creation
Moderna and Vertex Pharmaceuticals, two of the biggest biotechnology ... Biotechnology Council “industry snapshot.” Boston-based Vertex, which makes drugs for cystic fibrosis and is working ...
Nasdaq24d
What You Need to Know Ahead of Vertex Pharmaceuticals' Earnings Release
Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating cystic fibrosis (CF). Valued at $128.7 billion by market cap ...
Yahoo Finance5d
Vertex Pharmaceuticals Incorporated (VRTX)
BOSTON, November 04, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year ...
Nasdaq5d
Vertex Pharmaceuticals (VRTX) Just Overtook the 20-Day Moving Average
Vertex Pharmaceuticals (VRTX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, VRTX broke through the 20-day moving average ...
Seeking Alpha24d
Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride
Vertex's diverse pipeline, including Casgevy for SCD, suzetrigine for chronic pain, and the vanzacaftor triple for CF, positions it for growth despite launch challenges. Casgevy's complex ...
Seeking Alpha5d
Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated more than 40% since I shifted my coverage to hold/neutral last year, and I am not surprised since the company executed ...
Reuters6d
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Nov 4 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF ...
MarketWatch12d
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.26% to $470.36 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.16% ...
Morningstar3d
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...